Camp4 Therapeutics (CAMP) Earnings Date & Reports

Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CAMP is expected to report earnings to fall 56.90% to -25 cents per share on November 19

Camp4 Therapeutics CAMP Stock Earnings Reports

Q3'26

Est.

$-0.25

Q2'26

Missed

by $0.33

Q1'26

Missed

by $0.03

Q4'25

Missed

by $0.59

Q4'23

Missed

by $2.27

The last earnings report on August 13 showed earnings per share of -57 cents, missing the estimate of -25 cents. With 108.20K shares outstanding, the current market capitalization sits at 241.60M.

View a ticker or compare two or three

CAMP

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for CAMP